Guideline on neuromuscular blockade use in ARDS patients
Written By : Medha Baranwal
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2021-03-10 15:00 GMT | Update On 2021-03-10 15:00 GMT
Advertisement
Delhi: A panel of experts from 12 countries have released Intensive Care Medicine Rapid Practice Guideline (ICM-RPG) for the use of neuromuscular blocking agents (NMBA) in adults with acute respiratory distress syndrome (ARDS). The guideline, published in the journal Intensive Care Medicine, is applicable for adults with early ARDS of any aetiology and severity who are receiving invasive mechanical ventilation in an ICU. The recommendations however do not apply to patients with pre-existing neuromuscular disease, those with a contraindication to neuromuscular blockade, or to children.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.